Board of Directors of Extendicare Inc.

Alan D. Torrie (GN) (HR) Independent Director, Non-executive Chairman, Chair of the Governance and Nominating Committee

Mr. Torrie was appointed Chairman of the Board on May 25, 2017. Prior to that, he was the President and Chief Executive Officer of Morneau Shepell Inc. (from 2008 to May 2017), and was a member of its board of directors from 2005 to 2017. A TSX listed company, Morneau Shepell is a leading provider of employee and family assistance programs, the largest administrator of pension and benefits plans and the largest provider of integrated absence management solutions in Canada.

Previously, Mr. Torrie amassed extensive experience as a senior executive in the seniors’ housing and health and life science industries, including as Chief Operating Officer of Retirement Residences REIT from 2005 to 2007, before it was taken private as Revera Inc., and in a number of senior executive positions at MDS Inc. (a predecessor of Nordion Inc.) from 1987 to 2005, where he served as Executive Vice President of MDS Inc. (2003 to 2005), and as President and Chief Executive Officer of MDS Diagnostics and MDS Laboratories (1999 to 2003). He has also served as the President and Chief Executive Officer of Discovery Air Inc. (August 2017 to September 2018), as Executive-in-Residence with Clairvest Private Equity, a Toronto-based private equity management firm, and earlier in his career as the President and CEO of Joseph Brant Hospital and Chief Operating Officer and Vice President of Humber Memorial Hospital.

Mr. Torrie has served on numerous corporate and community boards and is currently a director and Chair of the Audit Committee of Flow Capital (a TSXV listed company) and a director and member of the audit and governance committees of Green Shield Canada. In addition, he previously served on the boards of Appleby College, as Chair of its Finance Committee, Trillium Health Partners, as its Chairman, and Cynapsus Therapeutics Inc., as a member of its Audit Committee. Mr. Torrie holds a B.Sc in Biochemistry from McMaster University, a DHA in Healthcare Management from the University of Toronto and has completed the Advanced Management Program from Harvard University. Mr. Torrie was appointed to the Board on January 6, 2016, and he resides in Toronto, Ontario.

Norma Beauchamp (I) (QR) Independent Director

Ms. Beauchamp has over 30 years of health care experience in corporate and non-profit organizations, including executive positions at Bayer Healthcare (Canada and Global) and Sanofi Canada. Most recently, she was President and CEO of Cystic Fibrosis Canada (2014 to 2017). Throughout her career, she has been a patient advocate, working with patient and health care organizations to enhance access to care.

Ms. Beauchamp currently serves on the boards of Acerus Pharmaceuticals Corporation (a TSX listed company), as Chair of its Corporate Governance and Nominating Committee and a member of its Audit Committee, Aurora Cannabis Inc. (a TSX listed company), as Chair of its Nominating and Corporate Governance Committee and a member of the compensation and scientific committees and Quest PharmaTech Inc. (a TSXV listed company). Formerly, Ms. Beauchamp was a director, Chair of the Corporate Governance and Compensation Committee and a member of the Audit Committee of MedReleaf.

Ms. Beauchamp has served on the Boards of St. Joseph’s Health Centre Foundation, Providence Healthcare Foundation and the Breast Cancer Society of Canada.

Ms. Beauchamp has completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D), and holds a Bachelor of Business Administration in Marketing from Bishop’s University. Ms. Beauchamp was appointed to the Board on May 30, 2019, and she resides in Toronto, Ontario.

Margery O. Cunningham (A) Independent Director, Chair of the Audit Committee

Ms. Cunningham is a corporate director and consultant, who most recently served as Vice President at Avalere Health, a leading advisory firm focused on health care business strategy and public policy, from August 2011 to October 2016. Prior thereto, Ms. Cunningham was with Lehman Brothers from 1997 to 2008, during which time she held a number of progressively senior executive roles, including as Managing Director and Global Head of Product Training, Associate Director of Credit Research and High Yield Bond Analyst. Her research career spanned more than 20 years, including both equity and fixed income research for firms such as Kidder, Peabody & Co., and Paine Webber. As an analyst, Ms. Cunningham was a perennial Institutional Investor magazine all-star analyst in the high yield health care category. In addition, from 1995 to 1997, Ms. Cunningham served as the Director, Financial Planning and Analysis for Marriott Management Services, performing strategic and financial analysis on acquisitions.

Ms. Cunningham is a CFA, and received her A.B. in Applied Mathematics from Harvard University and her M.S. in Management with concentration in Finance and Economics from the MIT Sloan School of Management. Ms. Cunningham was appointed to the Board on August 30, 2010, and she resides in New York, New York.

Dr. Michael Guerriere Non-independent Director, President and Chief Executive Officer

Dr. Guerriere was appointed Extendicare’s President and Chief Executive Officer effective October 22, 2018. A member of Extendicare’s Board of Directors since March 2018, Dr. Guerriere has a diverse background with over 25 years of experience in hospital operations, health management consulting and technology. Most recently, he served as Chief Medical Officer, Vice President and Chief Strategy Officer of TELUS Health, a provider of technology services to clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada. He also served ten years as an executive in university teaching hospitals, including as Executive Vice President and Chief Operating Officer at the University Health Network.

Dr. Guerriere has adjunct appointments in the Institute of Health Policy Management and Evaluation at the University of Toronto and the School of Health Information Science at the University of Victoria. He has served on numerous boards including Ryerson University (where he served as Chair), MediSolution Ltd. (member of audit committee), Canada Health Infoway (chair of finance committee), the Canadian Institute for Health Information (CIHI), and the Institute of Clinical Evaluative Sciences (ICES).

Dr. Guerriere holds a degree in Medicine and specialty training in Internal Medicine from the University of Toronto, an MBA from the Kellogg School of Management at Northwestern University and an honorary doctorate from Ryerson University. Dr. Guerriere was appointed to the Board in March 2018, and he resides in Toronto, Ontario.

Sandra L. Hanington (A) (GN) (QR) Independent Director, Chair of the Quality and Risk Committee

Ms. Hanington is a corporate director and advisor and most recently was the President and Chief Executive Officer of the Royal Canadian Mint (from February 2015 to July 2018). Prior to that she had deep experience in the financial services sector and served as Executive Vice President and a member of the Management Committee of BMO Financial Group. Ms. Hanington is co-founder and a director of Jack.org, promoting mental health and wellness for youth in Canada since 2010 and is the recipient of the Meritorious Service Cross from the office of the Governor General for her work with the organization.

Ms. Hanington was named by the Women’s Executive Network (WXN)™ as one of Canada’s Top 100 Most Powerful Women three times in a row, from 2007 to 2009 and was inducted into the WXN Hall of Fame in 2010. Ms. Hanington is a licensed professional engineer with a BASc from the University of Waterloo, an MBA from the Rotman School of Management, University of Toronto, and holds the ICD.D designation. Ms. Hanington was appointed to the Board in August 2014, and she resides in Toronto, Ontario.

Alan R. Hibben (A) (GN) (I) Independent Director

Mr. Hibben is a corporate director and advisor. Since December 2014, he has been the principal of Shakerhill Partners Ltd., a consulting firm providing strategic and financial advice, specializing in mergers and acquisitions, private equity, financing, corporate strategy, valuation, governance, as well as expert witness services. Previously, Mr. Hibben was the Managing Director in the Mergers and Acquisitions Group at RBC Capital Markets (March 2011 to December 2014). In addition, he had been a partner with Blair Franklin Capital Partners (2009 to 2011), and up until 2007, Mr. Hibben held the position of Head, Strategy & Development at RBC Financial Group, where he was responsible for corporate strategy as well as merger, acquisition and development activities for the bank. He was also Chief Executive Officer, RBC Capital Partners, the private equity investment arm of RBC Financial Group (2000 to 2007).

Mr. Hibben has been a director of a number of Canadian public and private companies, both in financial services and as part of his responsibility for overseeing private equity and venture capital investments. He currently serves as a director of DHX Media Ltd. (a TSX and NASDAQ listed company) and Home Capital Group Inc. (a TSX listed company), is Chair of Hudbay Minerals Inc (a TSX and NYSE listed company), and is on the board of the Mount Sinai Hospital Foundation, where he serves on the Sinai Health System Foundation’s Audit and Risk Committee as well as the Strategy Committee. Mr. Hibben is a CPA, CA, and CFA and holds the ICD.D designation. He was appointed to the Board on January 22, 2016, and he resides in Toronto, Ontario.

Donna E. Kingelin (HR) (QR) Independent Director, Chair of the Human Resources Committee

Ms. Kingelin is a corporate director and consultant, and is the retired owner and managing partner of Kingswood Consulting, a partnership that specialized in providing comprehensive services for seniors' housing companies (2012 to September 2017). She has over 30 years of leadership and operating experience in the senior living industry in public and private organizations that includes the administration of long-term care centres, retirement communities, and home care. Previously, Ms. Kingelin held the position of Managing Director at Holiday Corporation, a private independent retirement living company with over 300 communities across North America (June 2010 to June 2012). Prior to that, she was a senior executive at Revera Inc. (1997 to 2010), a seniors' housing company that is wholly owned by the Public Service Pension Investment Board (PSP Investments), and which was taken private in 2007 (formerly Retirement Residences REIT). Ms. Kingelin was Senior Vice President of Operations from 1997 to 2007, and Chief Operating Officer from 2007 to 2010, where she played a key role in taking the long-term care division public in 1997 as CPL Long Term Care REIT, followed by its acquisition in 2002 by Retirement Residences REIT, and back to private in 2007 when it was acquired by PSP Investments.

Ms. Kingelin is a member of the Oshawa Public Utility Board of Trustees and past Chair of its Human Resources Committee, as well as the Kinark Child and Family Services board, the Kinark Foundation and the Pallium Canada board. Ms. Kingelin previously served as a member and Chair of the Board of Trustees for Lakeridge Health, where she was Chair of its resource and quality committees and a member of its finance and audit committees, and was previously a member of the Ontario Long Term Care Association Board of Trustees, where she was the Chair of its Resident Care and Services Committee. She is a Registered Nurse, has earned the ICD.D designation from the Institute of Corporate Directors and has completed executive management training at Queens University. Ms. Kingelin was appointed to the Board on January 6, 2016, and she resides in Haydon, Ontario.

Samir Manji (I) Independent Director

Mr. Manji has over 25 years of experience in real estate and seniors housing and is the founder and CEO of Sandpiper Group, a Vancouver-based real estate private equity firm established in 2016. Prior to that, he was the founder, Chairman and CEO of Amica Mature Lifestyles Inc. (Amica), a TSX-listed company from 1997 until its sale to Ontario Teachers’ Pension Plan in 2015. Mr. Manji is widely credited with building Amica into the premier high-end independent living brand it is today.

Through his family-controlled company, Barney River Investments Ltd., Mr. Manji has been involved in over $3 billion in hospitality, seniors housing and multifamily residential real estate acquisitions and dispositions. Mr. Manji is an active member of the Young Presidents’ Organization and he is the current President of the Ismaili Council of British Columbia. He was recognized in 2006 as a recipient of Canada’s Top 40 Under 40 and was also named the Ernst & Young Entrepreneur of the Year award winner in the business-to-consumer products and services category in British Columbia in 2010.

Mr. Manji graduated from the University of Waterloo and received his CPA, CA with KPMG LLP in Toronto. He was appointed to the Board on May 30, 2019, and currently resides in Vancouver, British Columbia.

Al Mawani (A) (HR) (I) Independent Director, Chair of the Investment Committee

Mr. Mawani is the Principal of Exponent Capital Partners Inc., a private equity investor and real estate advisory firm. He has over 35 years of experience in the commercial real estate industry, including 15 years of c-suite experience as SVP/EVP & CFO of Oxford Properties Group Inc. from 1989 to 2001, President and CEO of Calloway/Smart Real Estate Investment Trust from 2011 to 2013, and President & CEO of privately-owned Rodenbury Investments Limited during 2015 and 2016.

Mr. Mawani has been an independent board member of national and North American firms across multiple asset classes, including private-pay retirement living operations. He currently serves on the TSX-listed boards of First Capital Realty Inc. as Chair of its Audit Committee and Granite Real Estate Investment Trust as Chair of its Corporate Governance & Nominating Committee and as a member of its Audit Committee, and is a member of the advisory board of Elevate Multi-family LP, a private real estate investment fund. In addition, he has served on the boards of Slate Office REIT, Boardwalk Real Estate Investment Trust, Calloway Real Estate Investment Trust, Amica Mature Lifestyles Inc., and IPC US Real Estate Investment Trust. Mr. Mawani is a CPA, CA, and has a Masters in Law from York University, an MBA from the University of Toronto and is a member of ICD. He was appointed to the Board on December 1, 2017, and he resides in Toronto, Ontario.

A: Audit Committee
GN: Governance and Nominating Committee
HR: Human Resources Committee
I: Investment Committee
QR: Quality and Risk Committee

Honorary Directors of Extendicare

  • George A. Fierheller - Honorary Director (former board member, April 1981 to June 2010)
  • Dr. Seth B. Goldsmith - Director Emeritus (former board member, 1995 to January 2016)
  • Alvin G. Libin - Director Emeritus (former board member, 1984 to January 2016)
  • J. Thomas MacQuarrie, Q.C. - Director Emeritus (former board member, 1980 to January 2016)